The Cooper Companies, Inc. (NASDAQ:COO) Shares Sold by Kintegral Advisory LLC

Kintegral Advisory LLC decreased its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 4.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 11,810 shares of the medical device company’s stock after selling 550 shares during the quarter. Kintegral Advisory LLC’s holdings in Cooper Companies were worth $1,086,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Navellier & Associates Inc. increased its holdings in shares of Cooper Companies by 30.5% in the fourth quarter. Navellier & Associates Inc. now owns 4,168 shares of the medical device company’s stock valued at $383,000 after purchasing an additional 975 shares during the last quarter. ING Groep NV purchased a new stake in Cooper Companies in the 4th quarter valued at $555,000. Handelsbanken Fonder AB increased its stake in shares of Cooper Companies by 14.6% in the 4th quarter. Handelsbanken Fonder AB now owns 627,522 shares of the medical device company’s stock worth $57,688,000 after acquiring an additional 79,853 shares during the last quarter. Ieq Capital LLC raised its holdings in shares of Cooper Companies by 8.7% during the 4th quarter. Ieq Capital LLC now owns 27,497 shares of the medical device company’s stock worth $2,528,000 after acquiring an additional 2,190 shares during the period. Finally, C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors acquired a new position in shares of Cooper Companies during the 4th quarter valued at about $691,000. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the stock. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research report on Friday, December 6th. Citigroup cut their price target on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a report on Friday, December 6th. StockNews.com lowered shares of Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday, December 11th. Wells Fargo & Company increased their price objective on Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research report on Friday, December 6th. Finally, Morgan Stanley reduced their target price on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research report on Friday, December 6th. Three equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $117.00.

Cooper Companies Trading Down 0.2 %

Shares of NASDAQ COO opened at $88.48 on Friday. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $17.66 billion, a PE ratio of 45.37, a PEG ratio of 2.25 and a beta of 1.00. The Cooper Companies, Inc. has a twelve month low of $84.76 and a twelve month high of $112.38. The stock has a fifty day simple moving average of $92.94 and a 200-day simple moving average of $99.60.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share for the quarter, beating the consensus estimate of $1.00 by $0.04. The company had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.03 billion. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. Cooper Companies’s revenue was up 9.8% compared to the same quarter last year. During the same period in the previous year, the company posted $0.87 EPS. On average, equities analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.